Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Third Chamber) of 6 November 2024 –  
Stada Arzneimittel v EUIPO – Bioiberica (DAOgest)

(Case T‑396/23) (
[1](#t-ECR_62023TJ0396_INF_EN_01-E0001)
)

(EU trade mark – Opposition proceedings – Application for EU word mark DAOgest – Earlier EU word mark DAOSIN – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EU) 2017/1001)

| 1. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Likelihood of confusion with the earlier mark – Assessment of the likelihood of confusion – Determination of the relevant public – Level of attention of the public – Health products  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 18-24, 28) |

| 2. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Likelihood of confusion with the earlier mark – Word marks DAOgest and DAOSIN  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 25, 31, 47, 53, 62, 64) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Similarity between the marks concerned – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 38, 39, 41, 42, 46) |

| 4. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Likelihood of confusion with the earlier mark – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 57-59) |

| 5. | EU trade mark – Appeals procedure – Action before the EU judicature – Power of the General Court to alter the contested decision – Limits  (European Parliament and Council Regulation 2017/1001, Art. 72(3))  (see paragraph 63) |

Operative part

The Court:

| 1. | Annuls the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 25 April 2023 (Case R 1384/2022‑2); |

| 2. | Orders EUIPO to bear its own costs and to pay those incurred by Stada Arzneimittel AG; |

| 3. | Orders Bioiberica, SAU to bear its own costs. |

---

(
[1](#c-ECR_62023TJ0396_INF_EN_01-E0001)
) [OJ C 314, 4.9.2023](./../../../legal-content/EN/AUTO/?uri=OJ:C:2023:314:TOC).

[Top](#document1)